by Nick | Aug 8, 2022 | Clinical Research, oncology
In the last few years, a major breakthrough in cancer research has occurred: early phase oncology trials. This type of trial is designed to test whether a new drug has any adverse effects on people and also provides anecdotal evidence that it might be efficacious.... 
by Nick | Jul 23, 2022 | Clinical Research, EAEU
Moving Clinical Trials away from Ukraine and Russia Russia, Ukraine, and other CIS countries have been significant contributors to clinical trials in many therapeutic areas for several years. With access to experienced investigators, good quality, and large patient... 
by Nick | Jul 16, 2022 | Clinical Research, EAEU
Moving Clinical Trials away from Ukraine and Russia For a long time, Russia, Ukraine and other countries in the Commonwealth of Independent States (CIS) have been the host of ample clinical trials in various therapeutic areas. And for a good reason: countries in the... 
by Kamile Gruduls | Jun 10, 2022 | Clinical Research, Webinar
Webinar: How to Avoid Delays in Your Early Phase Oncology Trial? Many things can go array in your early phase oncology trials, from protocol development, taking care of a safety profile, getting the ethics committee / regulatory authority’s approval, managing vendors,... 
by Kamile Gruduls | Mar 25, 2022 | Clinical Research, Pharmacovigilance, Regulatory Affairs, Webinar
Webinar: How does the conflict between UA & RU impact the pharma industry? Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability to continue operations. And with good reason. Russia’s invasion of... 
by Nick | Mar 10, 2022 | Clinical Research, Pharmacovigilance, Regulatory Affairs
Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability to continue operations. And, with good reason. Russia’s invasion of Ukraine affects millions of people, not just in this Eastern European nation but... 
